Wolverine Trading’s Cytosorbents Corp CTSO Stock Holding History

Wolverine Trading’s Portfolio CTSO Stock Details CTSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-11,300	Closed	-$39K	–	4351
2023 Q1	$39K	Sell	11,300 -9,900	-47%	-$29.7K	﹤0.01%	3886
2022 Q4	$33K	Sell	21,200 -2,700	-11%	-$4.01K	﹤0.01%	3662
2022 Q3	$32K	Buy	+23,900	New	+$46.7K	﹤0.01%	4277
2021 Q2	–	Sell	-12,200	Closed	-$103K	–	6116
2021 Q1	$103K	Buy	+12,200	New	+$116K	﹤0.01%	5423
2020 Q3	–	Sell	-21,700	Closed	-$212K	–	4602
2020 Q2	$212K	Buy	+21,700	New	+$199K	﹤0.01%	3755
2019 Q1	–	Sell	-10,600	Closed	-$83K	–	4638
2018 Q4	$83K	Sell	10,600 -2,100	-17%	-$20.9K	﹤0.01%	4039
2018 Q3	$164K	Sell	12,700 -14,500	-53%	-$182K	﹤0.01%	4346
2018 Q2	$192K	Hold	27,200	–	–	﹤0.01%	4411
2018 Q1	$192K	Buy	+27,200	New	+$206K	﹤0.01%	4411
2017 Q4	–	Sell	-20,400	Closed	-$126K	–	4998
2017 Q3	$126K	Buy	20,400 +7,600	+59%	+$38.7K	﹤0.01%	3995
2017 Q2	$56K	Buy	+12,800	New	+$56.1K	﹤0.01%	4033

Other funds holding CTSO

Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return

Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JAMONY

Jacob Asset Management of New York Hermosa Beach, California $70.9M AUM 14.28% 1-Year Est. Return

Wolverine Trading's CTSO Position: Q2 2020 in Review

Wolverine Trading sold out of Cytosorbents Corp (CTSO) in Q2 2020, closing a stake of 25,735 shares — an estimated $236K sold.

Wolverine Trading first reported a position in CTSO in Q2 2016 and held it in 12 quarters. The position peaked at $222K in Q3 2018. 91 funds tracked by Wall St. Rank hold CTSO as of Q2 2020.

Wolverine Trading reported no remaining Cytosorbents Corp position as of Q2 2020 after selling out during the quarter.
Wolverine Trading sold 25,735 Cytosorbents Corp shares in Q2 2020, an estimated $236K.
Wolverine Trading first reported a position in Cytosorbents Corp in Q2 2016 and held it in 12 quarters.
Wolverine Trading's Cytosorbents Corp position peaked at $222K in Q3 2018.
91 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2020.

Based on Wolverine Trading's 13F filing for Q2 2020, filed 13 Aug 2020.